If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSCPA.L Regulatory News (SCPA)

  • There is currently no data for SCPA

Form 8.3 - Scapa Group plc

15 Mar 2021 12:42

Magnetar Capital Partners LP - Form 8.3 - Scapa Group plc

Magnetar Capital Partners LP - Form 8.3 - Scapa Group plc

PR Newswire

London, March 15

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Identity of the person whose positions/dealings are being disclosed:Magnetar Capital Partners LP
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Scapa Group plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:N/A
(e) Date position held/dealing undertaken:March 12, 2021
(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?no

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:5p ordinary ISIN: GB0007281198
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:
(2) Derivatives (other than options):5,912,2093.15%
(3) Options and agreements to purchase/sell:
TOTAL:5,912,2093.15%

All interests and all short positions should be disclosed.

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other executive options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit

 (b) Derivatives transactions (other than options)

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
Ordinary sharesSwapincreasing a long position658,9532.1275

 (c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit

(ii) Exercising

Class of relevant securityProduct description e.g. call optionNumber of securitiesExercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)

The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?No

Date of disclosure:March 15, 2021
Contact name:Julianna Ethell
Telephone number:847-905-4688

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
12th Jun 20191:16 pmRNSDirector/PDMR Shareholding
12th Jun 20199:16 amRNSHolding(s) in Company
11th Jun 201910:28 amRNSHolding(s) in Company
10th Jun 20192:50 pmRNSAnnual Report and Notice of AGM
10th Jun 201910:05 amRNSHolding(s) in Company
10th Jun 20197:00 amRNSBoard update and additional information
3rd Jun 20194:32 pmRNSHolding(s) in Company
3rd Jun 20197:00 amRNSNotice of Termination of Material Contract
31st May 20199:19 amRNSTotal Voting Rights
28th May 201910:57 amRNSHolding(s) in Company
22nd May 20192:11 pmRNSHolding(s) in Company
21st May 20197:00 amRNSHeejae Chae to step down as Group CEO of Scapa
21st May 20197:00 amRNSScapa Group: Preliminary Results
30th Apr 20199:33 amRNSTotal Voting Rights
26th Apr 20192:21 pmRNSHolding(s) in Company
25th Apr 20192:15 pmRNSHolding(s) in Company
11th Apr 20197:00 amRNSYear-end trading update
29th Mar 20198:50 amRNSTotal Voting Rights
6th Mar 20194:12 pmRNSDirector/PDMR Shareholding
6th Mar 20199:43 amRNSPDMR Notification
28th Feb 20193:23 pmRNSTotal Voting Rights
12th Feb 20194:53 pmRNSDirector/PDMR Shareholding
8th Feb 20194:38 pmRNSDirector/PDMR Shareholding
25th Jan 20198:00 amRNSBlock listing Interim Review
23rd Jan 20197:00 amRNSCapital Markets Day
22nd Jan 20197:00 amRNSDirectorate Change
31st Dec 20189:08 amRNSTotal Voting Rights
21st Dec 201810:16 amRNSDirector/PDMR Shareholding
13th Dec 20184:40 pmRNSDirectorate Change
11th Dec 20182:52 pmRNSDirector/PDMR Shareholding
30th Nov 20189:35 amRNSTotal Voting Rights
23rd Nov 20184:05 pmRNSDirector/PDMR Shareholding
21st Nov 201810:46 amRNSDirector/PDMR Shareholding
20th Nov 20187:00 amRNSHalf-year Report
8th Nov 20184:08 pmRNSHolding(s) in Company
31st Oct 20189:57 amRNSTotal Voting Rights
10th Oct 20187:00 amRNSTrading Statement
2nd Oct 20187:00 amRNSAcquisition
28th Sep 201810:42 amRNSTotal Voting Rights
21st Sep 201812:27 pmRNSDirector/PDMR Shareholding
17th Sep 201810:07 amRNSAnnual Financial Report
13th Sep 20188:21 amRNSAcquisition
31st Aug 20189:53 amRNSTotal Voting Rights
24th Aug 20187:00 amRNSDirectorate Change
7th Aug 201811:59 amRNSBlock listing Interim Review
31st Jul 201810:11 amRNSTotal Voting Rights
26th Jul 20183:26 pmRNSBlock listing Interim Review
17th Jul 20182:46 pmRNSResult of AGM
17th Jul 20187:00 amRNSAGM Statement
10th Jul 20184:08 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.